SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-18-007560
Filing Date
2018-12-11
Accepted
2018-12-10 19:52:55
Documents
9

Document Format Files

Seq Description Document Type Size
1 424B5 a2237310z424b5.htm 424B5 395360
2 G950531.JPG g950531.jpg GRAPHIC 17021
3 G154378.JPG g154378.jpg GRAPHIC 37005
4 G412888.JPG g412888.jpg GRAPHIC 59320
5 G848284.JPG g848284.jpg GRAPHIC 49418
6 G45570.JPG g45570.jpg GRAPHIC 48070
7 G476183.JPG g476183.jpg GRAPHIC 90669
8 G491193.JPG g491193.jpg GRAPHIC 31557
9 G712315.JPG g712315.jpg GRAPHIC 8217
  Complete submission text file 0001047469-18-007560.txt   867469
Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-221266 | Film No.: 181227577
SIC: 2834 Pharmaceutical Preparations